MapDiff | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19 results for “MapDiff”

Trials

Tolerance and Acceptability Evaluation AYMES Cardiff

17 participants · First posted Jan 11, 2021

Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging

19 participants · First posted Oct 14, 2020

Drugs

Anti-LAG-3(Cardiff University)

dUTPase inhibitors(University of Cardiff)

Nucleic acids based therapeutics(Cardiff University)

Organizations

CARDIFF UNIVERSITY

United Kingdom

Cardiff Oncology

United States

CARDIFF METROPOLITAN UNIVERSITY

United Kingdom

News

AI Breakthrough Accelerates Protein Engineering for Next-Generation Therapeutics

Cardiff Oncology's Onvansertib Shows Promise in Metastatic Castration-Resistant Prostate Cancer

Cardiff Oncology's Onvansertib Shows Promising Results in RAS-Mutated Metastatic Colorectal Cancer Trial

Page 1 of 2